[ステロイド依存性/耐性慢性移植対宿主疾患におけるイブルチニブの有効性と安全性:単一センター分析]
Fumihiko Ouchi1, Yuho Najima1, Kana Kato1
1Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
イブルーチニブ (IBR) は,移植後の重度の慢性移植対宿主疾患 (cGVHD) の治療に適度な効果を示した. 高い感染率により,IBRの治療が頻繁に中止され,感染の注意深いモニタリングの必要性が強調されました.
科学分野:
- 血液学
- 免疫学
- 腫瘍学
さらに関連する動画
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
関連する概念動画
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Ulcerative Colitis in IBD
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
